Celastrol suppresses the growth of vestibular schwannoma in mice by promoting the degradation of β-catenin

References

Page 1

	Year	Citations
Zebrafish Prickle, a Modulator of Noncanonical Wnt/Fz Signaling, Regulates Gastrulation Movements Michael T. Veeman, Diane C. Slusarski, Ajamete Kaykas, Current Biology BiologyZebrafish PrickleDevelopmental BiologySignal TransductionPhysiology	2003	937
EANO guideline on the diagnosis and treatment of vestibular schwannoma Roland Goldbrunner, Michael Weller, Jean Régis, Neuro-Oncology Neuro-oncologySurgical OncologyVestibular SystemMedicineVestibular Schwannoma	2019	403
Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells Xihong Liu, Peiyuan Zhao, Xiujuan Wang, Journal of Experimental & Clinical Cancer Research	2019	216
A First-in-Human Phase I Study of the Anticancer Stem Cell Agent Ipafricept (OMP-54F28), a Decoy Receptor for Wnt Ligands, in Patients with Advanced Solid Tumors Antonio Jimeno, Michael A. Gordon, Rashmi Chugh, Clinical Cancer Research	2017	200
Chemotherapy-induced cardiotoxicity Maria Florescu, Mircea Cintezǎ, Dragoş Vinereanu Anti-Cancer Drugs CardiomyopathyHeart FailureCardiovascular DiseaseMedicineIrreversible Heart Failure	2011	139
Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression Yulun Huang, Youxin Zhou, Yisun Fan, Cancer Letters Tumor BiologyVegfr ExpressionHuman Glioma XenograftsNude MiceGlioma	2008	120
Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy Hyun‐Woo Lee, Kenny Seung Bin Jang, Hye Ji Choi, BMB Reports Cell AutophagyTherapeutic EffectChemoprevention StrategyMedicineApoptosis	2014	113
Wnt/β-catenin signaling in hepatic organogenesis Kari Nejak‐Bowen, Satdarshan P. Monga Organogenesis PathologyOrgan DevelopmentCholangiopathiesTissue DevelopmentSignaling Pathway	2008	103
Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy Babita Madan, Mitchell J. McDonald, Gabrielle E. Foxa, Bone Research Bone DiseaseBone LossBone HealthMetabolic Bone DiseaseMedicine	2018	97
Merlin-Deficient Human Tumors Show Loss of Contact Inhibition and Activation of Wnt/β-Catenin Signaling Linked to the PDGFR/Src and Rac/PAK Pathways Lü Zhou, Emanuela Ercolano, Sylwia Ammoun, Neoplasia	2011	91

Page 1